Pharmaceutical tablet

- Glaxo Wellcome Inc.
Skip to: Description  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view from above of the pharmaceutical tablet showing our design;

FIG. 2 is a side elevational view thereof, the opposite side elevational view being identical;

FIG. 3 is an end elevational view thereof, the opposite end elevational view being identical; and,

FIG. 4 is an underneath plan view thereof, the top plan view being identical.

Referenced Cited
U.S. Patent Documents
D286919 November 25, 1986 Flockhart
D296260 June 21, 1988 Hayes
D299275 January 3, 1989 Ott
D316616 April 30, 1991 Leslie et al.
3899603 August 1975 Brodie
4215104 July 29, 1980 Ullman et al.
4218433 August 19, 1980 Kooichi et al.
Foreign Patent Documents
Des. 61669 October 1972 AUX
Des. 90972 September 1985 AUX
Des. 101896 November 1988 AUX
Des. 101897 November 1988 AUX
Des. 108972 September 1990 AUX
Des. 111915 August 1991 AUX
Des. 48150 January 1981 CAX
Des. 57735 March 1986 CAX
Des. 34238 January 1984 FRX
Des. 233834 January 1987 FRX
2 224 390 December 1973 DEX
28 34 226 February 1980 DEX
Ses. 23664 December 1984 DEX
Des. 24549 July 1985 DEX
329055 April 1971 JPX
508547 August 1979 JPX
538262 August 1980 JPX
686484 September 1986 JPX
702577 April 1987 JPX
Des. 36855 April 1986 SEX
Des. 19277 March 1991 SEX
DM/000213 June 1980 WOX
DM/007721 November 1985 WOX
DM/007722 December 1985 WOX
DM/010438 March 1988 WOX
DM/020 828 October 1991 WOX
Other references
  • Hornung, C., Handbook of Designs and Devices, "The Quatrefoil," p. 24 (1946). Physicians Desk Reference 34th Edition, Product Identification: Lilly, Zentron Chewable, p. 416 (1980). Physicians Desk Reference 46th Edition, pp. 406, 408, 415, 416, 419,420 (1992). Physicians' Desk Reference Items--Abbott Oqen.RTM. (p. 403). Burroughs Wellcome Imuran.RTM. (p. 407). Mead Johnson Pharmaceuticals BuSpar.RTM. Tablets (p. 418). Merck Sharp & Dohme Hydro Control.RTM. (p. 418). Daniels Pharmaceuticals Levoxine.RTM. (p. 438), 1990, 44th Ed.
Patent History
Patent number: D398395
Type: Grant
Filed: Jun 22, 1992
Date of Patent: Sep 15, 1998
Assignee: Glaxo Wellcome Inc. (NC)
Inventors: Paul Charlton Titley (Dartford), Alexander McCall (Dartford), John Joe Atkins (Dartford)
Primary Examiner: M. H. Tung
Law Firm: Graham & James LLP
Application Number: 7/903,804
Classifications
Current U.S. Class: Tablet Or Caplet (1) (D24/101)
International Classification: 2801;